Hamburg, 20 May 2021. Today, the Jung Foundation for Science and Research presents its three awards for cutting-edge medicine in the fields of metabolism, natural product research, immunology and neurology. With a total prize fund of €540,000, they are among the most highly endowed medical awards in Europe.
Please download the press release here.
High resolution pictures can be downloaded here.
Jung Foundation for Science and Research honours Özlem Türeci, Stefan Rose-John and Achmed Mrestani with highly endowed medicine prizes
Hamburg, May 5, 2023. Yesterday evening, the Jung Foundation for Science and Research awarded its medical prizes, which are among the most highly endowed in Europe. The laureates: Professor Dr med. Dr h.c. mult. Özlem Türeci, Professor Dr rer. nat. Stefan Rose-John and Dr med. Achmed Mrestani were honoured with a total of 540,000 euros for their pioneering research. With personal speeches of thanks, they accepted the awards in front of an invited audience.
Download the press release here.
Download images from the event here.
Stefan Rose-John receives the 2023 Jung Gold Medal for Medicine for his life’s work in translational medicine
Hamburg, 4 May 2023. “The human body is an incredibly complex machine, and I was privileged to be involved in researching the biochemistry of the human immune system.” What intelligence agencies do at a large scale, biochemists research on a small scale – the decoding of communication. The latter focuses on examining the exchange of information between the body’s cells. And it is precisely in this area that Professor Stefan Rose-John has been working for a long period of time, most recently at the Biochemical Institute in the Faculty of Medicine at the University of Kiel – with a vast amount of curiosity and passion. Through the work he has carried out over the course of his career, he has provided a great service to medicine and paved the way for new medications and treatments. He not only succeeded in discovering a new signalling pathway of the interleukin-6 (IL-6) cytokine, but also in finding ways to inhibit this pro-inflammatory pathway without compromising the protective and regenerative properties of IL-6. The Jung Foundation for Science and Research is now recognising this work by awarding him the Jung Gold Medal for Medicine. Each year, the Jung Foundation gives this award to leading researchers who have made a significant contribution to the advancement of medical research and practice or who are still actively doing so. The award is a recognition of their lifetime achievements to date.
Hier finden Sie die Pressemitteilung zum Download.
Das Bildmaterial stellen wir Ihnen gern hier zur Verfügung.
Özlem Türeci receives the 2023 Jung Prize for Medicine for her research into the prevention and treatment of tumour diseases, infectious diseases and other serious illnesses
Hamburg, 4 May 2023. The potential of mRNA vaccines is shaping scientific discourse today in many ways. Having helped to alleviate the effects of the COVID-19 pandemic, this potential has now become widely known. However, the fundamental and translational research as well as the development of mRNA technology that enabled the fast response, development and thus rapid availability of a vaccine against COVID-19 began decades ago. As co-founder of BioNTech, Professor Özlem Türeci is a leader in this field. Her research in immunology and mRNA technology also highlights development potential beyond COVID-19 for the prevention and treatment of tumour diseases, infectious diseases and other serious illnesses. In recognition of her achievements, she receives the Jung Prize for Medicine, which is endowed with a total of 300,000 euros, from the Jung Foundation for Science and Research. Türeci can use the prize fund for her future research as she sees fit. The Jung Prize for Medicine has been awarded since 1976 and recognises the work of researchers who have made a significant contribution to the advancement of human medicine and whose work promises to continue to do so in the future. It is one of the most highly endowed medical awards in Europe.
Hier finden Sie die Pressemitteilung zum Download.
Das Bildmaterial stellen wir Ihnen gern hier zur Verfügung.
Achmed Mrestani receives the 2023 Jung Career Advancement Award for his research project on understanding the pathophysiology of neurological calcium channel defects
Hamburg, 4 May 2023. Epilepsy and migraine are some of the most common neurological disorders. “The two disorders show significant genetic overlap,” explains Achmed Mrestani, MD, physician in training at the Clinic and Polyclinic for Neurology at University of Leipzig Medical Center and a researcher at the Faculty of Medicine at the University of Leipzig. In part, they originate through a dysfunction of voltage-gated P/Q-type calcium channels caused by point mutations. But how does this affect the architecture of synapses? And what structural and functional changes occur as result of these point mutations? This is where Achmed Mrestani’s current research project comes in. He hopes that this will lead to new potential treatments that, in the best-case scenario, can intervene specifically in the molecular interactions within the active zone. To support this exciting work, the Jung Foundation for Science and Research is awarding Achmed Mrestani with the Jung Career Advancement Award, which is endowed with 210,000 euros. The financial support will be provided over the next three years and can be used as he sees fit to conduct his own research project. The Jung Career Advancement Award is specifically aimed at young researchers and is the only award offered by the Jung Foundation for Science and Research for which people can submit applications.
Hier finden Sie die Pressemitteilung zum Download.
Das Bildmaterial stellen wir Ihnen gern hier zur Verfügung.
Stefan Rose-John receives a prize for his life’s work and Achmed Mrestani is awarded as young researcher
Hamburg, 4 May 2023. New treatments against cancer, autoimmune diseases, migraine and epilepsy – these are some of the areas covered by the research results of this year’s award winners from the Jung Foundation for Science and Research. With their groundbreaking work, Professor Özlem Türeci, Professor Stefan Rose-John and Dr Achmed Mrestani have made a significant contribution to alleviating the suffering of patients in the future. They will be honoured for this work by the Jung Foundation for Science and Research at an awards ceremony held on 4 May at the Anglo-German Club in Hamburg. With the Jung Prize for Medicine, the Jung Gold Medal for Medicine and the Jung Career Advancement Award, the Jung Foundation presents three awards every year to recognise cutting-edge medical work undertaken by outstanding physicians and researchers. With a total sum of 540,000 euros, they are among the most highly endowed medical awards in Europe.
Hier finden Sie die Pressemitteilung zum Download.
Das Bildmaterial stellen wir Ihnen gern hier zur Verfügung.
Hamburg, 11/04/2023. What possibilities do mRNA agents open up for future cancer treatments? How can autoimmune diseases be combated with greater precision? And how do point mutations in the CACNA1A gene influence the onset of epilepsy and migraines? The 3rd Jung Symposium “Excellent medicine 2023” is the place to be for anyone who is intrigued by these questions. Here, the Jung Foundation for Science and Research will be unveiling the outstanding research findings of this year’s laureates. Attendees can look forward to talks by the doctor, immunologist and cancer researcher Prof. Dr. med. Dr. h.c. mult. Özlem Türeci, the translational neuroscientist Prof. Dr. rer. nat. Stefan Rose-John and young researcher Dr. med. Achmed Mrestani. The 3rd Jung Symposium will be broadcast live via video stream from 1 p.m. to 4 p.m. on 5 May 2023 and can either be watched online or attended in person at the Ian K. Karan auditorium of the University Medical Center Hamburg-Eppendorf (UKE). Interested parties will find the current programme and all key information at https://jung-stiftung.de/en/symposium-2023-en/. Attendance is free of charge.
You can find the press release for download here.
You can find the picture for download here.
Study draws ambivalent conclusion about Ernst Jung – foundation faces up to responsibility and and initiates comprehensive measures
Hamburg, 22 February 2023. The Jung Foundation for Science and Research plans to provide a total of 1,000,000 euros in funding to the Neuengamme Concentration Camp Memorial and Doctors Without Borders to support research into medical history and help people in need. These funding projects are currently being discussed with the supervisory authority for foundations. The Jung Foundation will also offer an annual fellowship for a thesis at the Institute for History and Ethics of Medicine at the University Medical Centre Hamburg-Eppendorf. These and further planned measures are adopted in response to the results of a study on Ernst Jung and his companies during the period of National Socialism. The study was initiated by the foundation itself.
You can find the press release for download here.
You can find the picture for download here.
Hamburg, 24. October 2022. Combined scientific and economic know-how: Since June, Professor Dr Blanche Schwappach-Pignataro, Dean of the Medical Faculty Hamburg, has been a member of the Scientific Advisory Board and Board of Trustees of the Hamburg Jung Foundation for Science and Research. This means that the respected molecular biologist is now the second woman on the foundation’s Board of Trustees, alongside Petra Scharner-Wolff, Chief Financial Officer of the Hamburg Otto Group.
You can download the full press release here.
Hamburg, 17. October 2022. A survey of the prestigious Jung Prize for Medicine by the Jung Foundation of Science and Research underscores its importance for independent scientific research. The 33 participants highlight two aspects in particular: the influence of the prize as a springboard for further awards and its particular flexibility in the use of prize money.
You can download the full press release here.
